Table S1. Top upregulated and downregulated canonical pathways and genes following treatment with AZD5363. from AKT Antagonist AZD5363 Influences Estrogen Receptor Function in Endocrine-Resistant Breast Cancer and Synergizes with Fulvestrant (ICI182780) <i>In Vivo</i>
收藏NIAID Data Ecosystem2026-05-16 收录
数据链接：
官方服务：
资源简介：
MCF7 and MCF7-LTED cells were treated {plus minus} AZD5363 for 24-hours and RNA was submitted to microarray analysis.
创建时间：
2015-09-01
